Metraipolis › archive › dc_e539376367de

Targeting the MAPK Pathway in Cancer — Europe PMC PMID:41516092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41516092
DOI
10.3390/ijms27010214
License (as archived)
solo-consultazione
Archived
2026-11-07T10:35:46.564Z
SHA-256 of the archived text
02f69688bba4ff30203830ac7ea73f3c331725fd84bda7f30e42e280ef047432
Stable URL of this page
https://metraipolis.com/documento/dc_e539376367de

How to cite

Targeting the MAPK Pathway in Cancer — Europe PMC PMID:41516092 — Europe PMC (en), https://europepmc.org/article/MED/41516092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e539376367de (Metraipolis archive dc_e539376367de, sha256 02f69688bba4ff30203830ac7ea73f3c331725fd84bda7f30e42e280ef047432)
BibTeX
@misc{dce539376367de,
  title = {Targeting the MAPK Pathway in Cancer — Europe PMC PMID:41516092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41516092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e539376367de; sha256 02f69688bba4ff30203830ac7ea73f3c331725fd84bda7f30e42e280ef047432},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41516092. Agents can read the archived copy with the MCP tool read_document.